APA vs COYA · P/E 7.2, $7.26B cap vs rev $7.9M
APA Corporation (APA) versus Coya Therapeutics, Inc. Common Stock (COYA) — a side-by-side from cached financials, not a winner call.
APA Corporation (APA) is a oil & gas e&p company listed on US.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
APA does not have a complete income-statement cache yet.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
APA currently screens at market cap $7.26B and trailing P/E 7.2. COYA currently screens at market cap $118.0M.
Not investment advice. Open the APA and COYA stock pages for the full models.
Not investment advice.